PATENT CLAIM ANALYSIS

Application Number: 16125373
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "292000"]

Abstract:
The present invention relates to certain PDE2 inhibitory compounds, in free or salt form, pharmaceutical compositions containing such compounds and methods for the treatment of PDE2 mediated disorders.

Claim (Index 6):
A method for the treatment of a PDE2 mediated disorder comprising administering to a subject in need thereof an effective amount of a compound according to  claim 1 .

Metadata:
- Claim Count in Document: 14.0
- Percentile: 97.0
- Lexical Diversity: 1.10714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15533525', '13128726', '15533527', '11991858', '15502144']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7546844407153803
- 35 USC 102 Novelty (BERT): 0.6005099732264758
- Combined Prediction Score: 0.73926699396649
- Mean Citation Score: 385.984218
- Max Citation Score: 554.9456
- Similarity Product: 435.3357391652107

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test